Solara Active Pharma Sciences has informed that meeting of Board of Directors of the company held today November 11, 2021, the Directors has approved Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) along with the Limited Review Report by the Auditors and press release is attached. The Board Meeting commenced at 11.30 am and concluded at 2.15 pm.
The above information is a part of company’s filings submitted to BSE.
